Earnings Call · Q3 FY2024·2024-11-12

Q3 24EPS -12.99%·Rev n/aQ2 24EPS -49.68%·Rev n/aQ1 24EPS +19.46%·Rev n/aQ4 23EPS +2.33%·Rev n/a⚠ consensus missing

Arcadia Biosciences, Inc. RKDA

Mark Kawakami — Chief Financial Officer

T.J. Schaefer — President and Chief Executive Officer

−1.2%1d on move date−1.2% vs SPY3d−31.6%5d−33.0%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RKDA calls or request research access.

More RKDA calls Browse calls Request research access